[Federal Register Volume 87, Number 38 (Friday, February 25, 2022)]
[Notices]
[Pages 10819-10820]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04062]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-966]


Bulk Manufacturer of Controlled Substances Application: S&B 
Pharma LLC

AGENCY: Drug Enforcement Administration, Justice.

[[Page 10820]]


ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: S&B Pharma LLC has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before April 26, 2022. 
Such persons may also file a written request for a hearing on the 
application on or before April 26, 2022.

ADDRESSES:  Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on December 24, 2021, S&B Pharma LLC, 405 South Motor 
Avenue, Azusa, California 91702, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid..............     2010  I
Marihuana..............................     7360  I
Tetrahydrocannabinols..................     7370  I
Amphetamine............................     1100  II
Methamphetamine........................     1105  II
Lisdexamfetamine.......................     1205  II
Methylphenidate........................     1724  II
Pentobarbital..........................     2270  II
4-Anilino-N-Phenethyl-4-Piperidine          8333  II
 (ANPP).
Tapentadol.............................     9780  II
Fentanyl...............................     9801  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for the internal use intermediates for formulation and 
analytical development purposes or for sale to its customers. In 
reference to dug codes 7360 (Marihuana), and 7370 
(Tetrahydrocannabinols), the company plans to bulk manufacture these 
drugs as synthetic. No other activities for these drug codes are 
authorized for this registration.

Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-04062 Filed 2-24-22; 8:45 am]
BILLING CODE 4410-09-P